<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03459833</url>
  </required_header>
  <id_info>
    <org_study_id>PE:HA glans augmentation</org_study_id>
    <nct_id>NCT03459833</nct_id>
  </id_info>
  <brief_title>Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation</brief_title>
  <official_title>Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation: Randomized Controlled Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled cross-over study aims to evaluate the effect and safety of glans
      penis augmentation using Hyaluronic acid in the treatment of premature ejaculation in compare
      with placebo .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 19, 2016</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Patients with premature ejaculation according to the definition of Fourth International Consultation on Sexual Medicine 2015</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IELT</measure>
    <time_frame>Change from baseline after one month</time_frame>
    <description>Intra-vaginal Ejaculation Latency Time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AIPE</measure>
    <time_frame>Change from baseline after one month</time_frame>
    <description>Arabic index of premature ejaculation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IELT</measure>
    <time_frame>Change from baseline after three, six and nine months</time_frame>
    <description>Intra-vaginal Ejaculation Latency Time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Premature Ejaculation</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 patients They will receive a topical anesthetic agent for 30 minutes (Emla cream; lidocaine 25 mg, prilocaine 25 mg, Astra Xeneca, Mississauga, Canada) followed by injection of two prefilled 1 ml syringes with 30 G needle of hyaluronic acid (HA; TeosyalÂ® PureSense Global Action, Teoxane Laboratories, Geneva, Switzerland). After 18 months from the HA injection, cross-over to placebo arm will be done.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>They receive by the same method 2 ml saline as a placebo. After one month of the injection, cross-over to HA arm will be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronic Acid</intervention_name>
    <description>Glans penis augmentation using multiple puncture technique as described by Abdallah et al. (2012) with minor modifications. HA is injected at two circular levels: one at the level of corona of glans penis and a second circular level is mid-way between the corona and urethral meatus. Six injections are injected at coronal level and four are injected in the second level, each injection is of 0.2 ml and is injected into deep dermis.</description>
    <arm_group_label>group 1</arm_group_label>
    <arm_group_label>group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  occurrence of ejaculation in patients with lifelong premature ejaculation (LL PE)
             within 1 minute form vaginal penetration in all or almost all occasions starting from
             the first sexual experience, and within 3 minutes in patients with acquired premature
             ejaculation (A PE), along with inability to delay ejaculation on all or nearly all
             vaginal penetrations, with negative personal consequences, such as distress, bother,
             frustration, and/or the avoidance of sexual intimacy

        Exclusion Criteria:

          -  Erectile dysfunction

          -  Hypo or hyperthyroidism

          -  Hypogonadism

          -  Hyperprolactinemia

          -  Drug abuse

          -  Psychiatric disorders or related medications
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamed A Hamed, MD</last_name>
    <role>Study Director</role>
    <affiliation>Professor of Andrology, Cairo University</affiliation>
  </overall_official>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2018</study_first_posted>
  <last_update_submitted>March 10, 2018</last_update_submitted>
  <last_update_submitted_qc>March 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamed Wael Ragab</investigator_full_name>
    <investigator_title>Clinical demonstrator</investigator_title>
  </responsible_party>
  <keyword>premature ejaculation</keyword>
  <keyword>IELT</keyword>
  <keyword>hyaluronic acid</keyword>
  <keyword>glans penis augmentation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Premature Ejaculation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

